Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Oncological Medicine
Volume 2015, Article ID 345804, 5 pages
http://dx.doi.org/10.1155/2015/345804
Case Report

Superior Vena Cava Syndrome and Colon Carcinoma: A Report of a Multifactorial Association

1Internal Medicine Department A, University Hospital Center of Coimbra, 3000-075 Coimbra, Portugal
2General Surgery Department B, University Hospital Center of Coimbra, 3000-075 Coimbra, Portugal

Received 5 December 2014; Accepted 17 February 2015

Academic Editor: Jose I. Mayordomo

Copyright © 2015 Joana Espírito Santo et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. L. D. Wilson, F. C. Detterbeck, and J. Yahalom, “Superior vena cava syndrome with malignant causes,” The New England Journal of Medicine, vol. 356, no. 18, pp. 1862–1869, 2007. View at Publisher · View at Google Scholar · View at Scopus
  2. T. W. Rice, R. M. Rodriguez, and R. W. Light, “The superior vena cava syndrome: clinical characteristics and evolving etiology,” Medicine, vol. 85, no. 1, pp. 37–42, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. G. Y. Lip, B. S. Chin, and A. D. Blann, “Cancer and the prothrombotic state,” Lancet Oncology, vol. 3, no. 1, pp. 27–34, 2002. View at Publisher · View at Google Scholar · View at Scopus
  4. M. B. Streiff, “Association between cancer types, cancer treatments, and venous thromboembolism in medical oncology patients,” Clinical Advances in Hematology and Oncology, vol. 11, no. 6, pp. 349–357, 2013. View at Google Scholar · View at Scopus
  5. F. Horsted, J. West, and M. J. Grainge, “Risk of venous thromboembolism in patients with cancer: a systematic review and meta-analysis,” PLoS Medicine, vol. 9, no. 7, Article ID e1001275, 2012. View at Publisher · View at Google Scholar · View at Scopus
  6. A. Alcalay, T. Wun, V. Khatri et al., “Venous thromboembolism in patients with colorectal cancer: incidence and effect on survival,” Journal of Clinical Oncology, vol. 24, no. 7, pp. 1112–1118, 2006. View at Publisher · View at Google Scholar · View at Scopus
  7. A. D. Blann and S. Dunmore, “Arterial and venous thrombosis in cancer patients,” Cardiology Research and Practice, vol. 2011, Article ID 394740, 11 pages, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. H. T. Sørensen, L. Mellemkjær, F. H. Steffensen, J. H. Olsen, and G. L. Nielsen, “The risk of a diagnosis of cancer after primary deep venous thrombosis or pulmonary embolism,” The New England Journal of Medicine, vol. 338, no. 17, pp. 1169–1173, 1998. View at Publisher · View at Google Scholar · View at Scopus
  9. B. S. N. Alzand, Z. Geyik, R. Dennert, and E. C. Cheriex, “Superior vena cava syndrome as a complication of colon carcinoma,” International Journal of Cardiology, vol. 132, no. 1, pp. e45–e47, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Bockorny, T. Kourelis, and B. Bockorny, “Superior vena cava syndrome caused by colon adenocarcinoma metastasis: a case report and review of literature,” Connecticut Medicine, vol. 76, no. 2, pp. 77–80, 2012. View at Google Scholar · View at Scopus
  11. T. Uchiyama, M. Matsumoto, and N. Kobayashi, “Studies on the pathogenesis of coagulopathy in patients with arterial thromboembolism and malignancy,” Thrombosis Research, vol. 59, no. 6, pp. 955–965, 1990. View at Publisher · View at Google Scholar · View at Scopus
  12. G. H. Sack Jr., J. Levin, and W. R. Bell, “Trousseau's syndrome and other manifestations of chronic disseminated coagulopathy in patients with neoplasms: clinical, pathophysiologic, and therapeutic features,” Medicine, vol. 56, no. 1, pp. 1–37, 1977. View at Publisher · View at Google Scholar · View at Scopus
  13. M. Levi, “Disseminated intravascular coagulation in cancer patients,” Best Practice and Research: Clinical Haematology, vol. 22, no. 1, pp. 129–136, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. S. Sallah, J. Y. Wan, N. P. Nguyen, L. R. Hanrahan, and G. Sigounas, “Disseminated intravascular coagulation in solid tumors: clinical and pathologic study,” Thrombosis and Haemostasis, vol. 86, no. 3, pp. 828–833, 2001. View at Google Scholar · View at Scopus
  15. R. W. Colman and R. N. Rubin, “Disseminated intravascular coagulation due to malignancy,” Seminars in Oncology, vol. 17, no. 2, pp. 172–186, 1990. View at Google Scholar · View at Scopus
  16. P. Prandoni, A. W. A. Lensing, A. Piccioli et al., “Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis,” Blood, vol. 100, no. 10, pp. 3484–3488, 2002. View at Publisher · View at Google Scholar · View at Scopus
  17. A. A. Khorana, C. W. Francis, N. Blumberg, E. Culakova, M. A. Refaai, and G. H. Lyman, “Blood transfusions, thrombosis, and mortality in hospitalized patients with cancer,” Archives of Internal Medicine, vol. 168, no. 21, pp. 2377–2381, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. G. Balta, C. Altay, and A. Gurgey, “PAI-1 gene 4G/5G genotype: a risk factor for thrombosis in vessels of internal organs,” The American Journal of Hematology, vol. 71, no. 2, pp. 89–93, 2002. View at Publisher · View at Google Scholar · View at Scopus
  19. R. Seguí, A. Estellés, Y. Mira et al., “PAI-1 promoter 4G/5G genotype as an additional risk factor for venous thrombosis in subjects with genetic thrombophilic defects,” British Journal of Haematology, vol. 111, no. 1, pp. 122–128, 2000. View at Google Scholar · View at Scopus
  20. E. J. Weiss, P. F. Bray, M. Tayback et al., “A polymorphism of a platelet glycoprotein receptor as an inherited risk factor for coronary thrombosis,” The New England Journal of Medicine, vol. 334, no. 17, pp. 1090–1094, 1996. View at Publisher · View at Google Scholar · View at Scopus
  21. D. Ardissino, P. M. Mannucci, P. A. Merlini et al., “Prothrombotic genetic risk factors in young survivors of myocardial infarction,” Blood, vol. 94, no. 1, pp. 46–51, 1999. View at Google Scholar · View at Scopus
  22. Y.-I. Kim, “Role of the MTHFR polymorphisms in cancer risk modification and treatment,” Future Oncology, vol. 5, no. 4, pp. 523–542, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. G. Toffoli and E. de Mattia, “Pharmacogenetic relevance of MTHFR polymorphisms,” Pharmacogenomics, vol. 9, no. 9, pp. 1195–1206, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. P. Zhang, X. Gao, Y. Zhang et al., “Association between MTHFR C677T polymorphism and venous thromboembolism risk in the Chinese population: a meta-analysis of 24 case-controlled studies,” Angiology, 2014. View at Publisher · View at Google Scholar
  25. P. D. Stein, A. Beemath, and R. E. Olson, “Obesity as a risk factor in venous thromboembolism,” The American Journal of Medicine, vol. 118, no. 9, pp. 978–980, 2005. View at Publisher · View at Google Scholar · View at Scopus
  26. K. H. Borch, C. Nyegaard, J.-B. Hansen et al., “Joint effects of obesity and body height on the risk of venous thromboembolism: the tromsø study,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 31, no. 6, pp. 1439–1444, 2011. View at Publisher · View at Google Scholar · View at Scopus